Overview
Status
Active
Registry date
2023-07-24
Share capital
5,000.00 PLN
Registered address
Rondo Ignacego Daszyńskiego 2B, 00-843 Warszawa, Poland
Electronic delivery address
AE:PL-92171-48230-RVATR-07
Financials
Revenue history (in k)
Filing timeliness
Financial statements were filed on time, on average 56 days early.
- 202514/07/2026
- 202402/05/2025
- 202312/04/2024
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 871.44kMedianUSD 112.93kAverageUSD 1.39m
Net profit
This companyUSD 39.31kMedianUSD 3.36kAverageUSD 117.95k
Operating costs
This companyUSD 817.18kMedianUSD 100.06kAverageUSD 1.26m
Assets
This companyUSD 279.88kMedianUSD 92.09kAverageUSD 1.28m
Industry
Authorized Representatives
Alexandros Jacovides – President of the Management Board
Christophoros Papachristophorou – Management Board Member
Constantinos Evripides – Management Board Member
Manner of representation
Each member of the management board has the right to represent the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Genesis Pharma (cyprus) Ltd. | 100 | $1,350.62 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2023-08-09.
54 1090 2398 0000 0001 5432 4446
87 1090 2398 0000 0001 5859 2046
85 1090 2398 0000 0001 5946 9641
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Target Pointsp. z o.o. | $1,420,831.09 | targetpoint.pl | ||
| Wiserabbitsp. z o.o. | $1,363,268.00 | wiserabbit.co | ||
| Centrum Badań Marketingowych Indicatorsp. z o.o. | $1,269,397.82 | indicator.pl | ||
| Tgthsp. z o.o. | $690,714.96 | tgth.pl | ||
| Maison & Partnerssp. z o.o. | $554,241.32 | maison.pl | ||
| Cxstreamsp. z o.o. | $546,554.22 | cxstream.pl | ||
| Gold Minerssp. z o.o. | $393,943.74 | fokusowniabit.pl | ||
| Stratosfera Consultingsp. z o.o. | $356,518.01 | stratosfera.com | ||
| Professional Benchmark Consultingsp. z o.o. | $210,591.65 | professionalbenchmark.com | ||
| Open Researchsp. z o.o. | $101,712.92 | openresearch.pl |
FAQ
The main business activity of Genesis Biopharma Poland focuses on market research and public opinion polling.
The company was registered in the Polish National Court Register (KRS) on July 24, 2023.
The headquarters is located at: Rondo Ignacego Daszyńskiego 2B, 00-843 Warszawa.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
The company reported a revenue of $534,584 in 2024, which is an increase of 790194144.4% compared to 2023.
Yes, the company recorded a net profit of $14,513 in 2024.
The largest operating cost category falls under external services. This category amounted to $209,789 in 2024, representing 42% of all operating expenses.
Last updated: 2026-10-07